The effect of pramiracetam in the myelination of the hippocampus in the BALB/c mouse (Mus musculus)

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 3

Abstract

Background: Pramiracetam is being used, particularly by students, to increase cognitive function and enhance learning and memory. There are currently sparse data on the effect of pramiracetam, particularly in the brain. One recent study showed that there is an increased nitric oxide synthase (NOS) in systemically administered pramiracetam. Aims and Objectives: To determine if there would be a demyelinating effect in the hippocampus that is a sign of neurological damage due to increasing nitric oxide synthase. Materials and Methods: A total of fifteen mice were given 200 and 600 mg/kg dose of pramiracetam for qualitative histological comparison of their hippocampal myelination. After administration with food of the pramiracetam for 75 days, the mice were sacrificed and the brains were then extracted intact, and sagittal sections of the brain were made and stained with the Klüver-Barrera method. Hippocampi were analyzed using a compound microscope to observe for demyelination and neuronal degeneration. Results: Based on histological analysis, there were no signs of demyelination in the hippocampus of the Mus musculus brain. This may indicate that pramiracetam does not cause demyelination that may be due to increased NO production. Conclusion: Pramiracetam may be safe to take at doses of 200–600 mg/kg without any demyelinating effects in mouse.

Authors and Affiliations

Adrian Cielo S Angeles, Michael B Ples, Rodel Jonathan S Vitor

Keywords

Related Articles

Condition of inflammation mediators and antioxidant protection system for endometriosis genitalis in women of reproductive age

Background: The paper presents the data on a condition and a role of inflammation mediators and the antioxidant protection system in blood plasma for endometriosis genitalis (EG) in women of reproductive age. The materia...

Investigation of the antioxidant activity of hesperidin against 6-hydroxydopamine-induced cell damage in SH-SY5Y cells

Background: Parkinson’s disease (PD) is regarded as a neurological condition in which continuous degeneration of dopaminergic neurons occurs selectively. Currently, most treatments for neurodegenerative diseases are pall...

Use of mini-CEX as a teaching learning method in physiology for undergraduate medical students

Background: Most of the assessments of medical students are at the end of the term or year leaving hardly any scope for feedback. Mini-clinical evaluation exercise (mini-CEX) is a hybrid tool that allows assessment as we...

Antidiuretic hormone effect on transport of non-charged solutes (urea and glycerol) across the epithelium

Background: The frog skin epithelium is used as a model to demonstrate the transport of various charged and non-charged solutes from the mucosal to serosal side through channels and transporters. The mucosal side, otherw...

An assessment of adverse reactions to antiretroviral therapy in a South Indian government hospital

Background: Adverse drug reactions (ADRs) can lead to non-adherence to antiretroviral therapy (ART) and are also the major causes of hospitalization and higher cost of treatment. Aims and Objectives: The aims of this stu...

Download PDF file
  • EP ID EP487194
  • DOI 10.5455/njppp.2017.7.0832609112017
  • Views 62
  • Downloads 0

How To Cite

Adrian Cielo S Angeles, Michael B Ples, Rodel Jonathan S Vitor (2018). The effect of pramiracetam in the myelination of the hippocampus in the BALB/c mouse (Mus musculus). National Journal of Physiology, Pharmacy and Pharmacology, 8(3), 431-435. https://europub.co.uk/articles/-A-487194